FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 161 filers reported holding FATE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $2,110,000 | +46.0% | 23,209 | -35.8% | 0.35% | +0.9% |
Q3 2020 | $1,445,000 | -15.9% | 36,160 | -27.8% | 0.34% | -9.7% |
Q2 2020 | $1,719,000 | +14.4% | 50,110 | -25.9% | 0.38% | -18.5% |
Q1 2020 | $1,502,000 | +150.8% | 67,647 | +75.5% | 0.47% | +194.9% |
Q3 2019 | $599,000 | -58.3% | 38,540 | -45.6% | 0.16% | -55.0% |
Q2 2019 | $1,437,000 | +15.5% | 70,799 | 0.0% | 0.35% | +15.1% |
Q1 2019 | $1,244,000 | +21.6% | 70,799 | -11.2% | 0.30% | +9.7% |
Q4 2018 | $1,023,000 | -23.2% | 79,716 | -2.5% | 0.28% | +40.4% |
Q3 2018 | $1,332,000 | +90.6% | 81,743 | +32.5% | 0.20% | +80.0% |
Q2 2018 | $699,000 | -74.3% | 61,681 | -77.9% | 0.11% | -75.8% |
Q1 2018 | $2,725,000 | – | 279,161 | – | 0.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |